Are typical human serum BPA concentrations measurable and sufficient to be estrogenic in the general population?

Food and Chemical Toxicology

Volumn 62, Issue , 2013, Pages 949-963

  Teeguarden, Justin ^a   Hanson Drury, Sesha ^a   Fisher, Jeffrey W ^b   Doerge, Daniel R ^b  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Biomonitoring; BPA; Epidemiology; Estrogenic; Toxicity

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RELATED RECEPTOR GAMMA; G PROTEIN COUPLED RECEPTOR 30; STEROID RECEPTOR; UNCLASSIFIED DRUG; BENZHYDRYL DERIVATIVE; ESTROGEN; ESTROGEN RECEPTOR; PHENOL DERIVATIVE;

ANALYTIC METHOD; BINDING AFFINITY; BIOLOGICAL ACTIVITY; BLOOD LEVEL; ESTROGEN BINDING; HUMAN; MEASUREMENT; POPULATION RESEARCH; RECEPTOR AFFINITY; REVIEW; ADULT; ANALYSIS; BLOOD; ENVIRONMENTAL EXPOSURE; FEMALE; HOSPITAL; INFANT; META ANALYSIS; METABOLISM;

MAMMALIA;

ADULT; BENZHYDRYL COMPOUNDS; ENVIRONMENTAL EXPOSURE; ESTROGENS, NON-STEROIDAL; FEMALE; HOSPITALS; HUMANS; INFANT; PHENOLS; RECEPTORS, ESTROGEN;

EID: 84888136772     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.08.001     Document Type: Review

References (117)

1. Alonso-Magdalena P., Morimoto S., Ripoll C., Fuentes E., Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ. Health Perspect. 2006, 114:106-112.
2. Alonso-Magdalena P., Ropero A.B., Carrera M.P., Cederroth C.R., Baquie M., Gauthier B.R., Nef S., Stefani E., Nadal A. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS One 2008, 3:e2069.
3. Arakawa C., Fujimaki K., Yoshinaga J., Imai H., Serizawa S., Shiraishi H. Daily urinary excretion of bisphenol A. Environ. Health Prev. Med. 2004, 9:22-26.
4. Baumann C.K., Castiglione-Gertsch M. Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer. Minerva Ginecol. 2009, 61:517-539.
5. Becker K., Goen T., Seiwert M., Conrad A., Pick-Fuss H., Muller J., Wittassek M., Schulz C., Kolossa-Gehring M. GerES IV: phthalate metabolites and bisphenol A in urine of German children. Int. J. Hyg. Environ. Health 2009, 212:685-692.
6. Benachour N., Aris A. Toxic effects of low doses of Bisphenol-A on human placental cells. Toxicol. Appl. Pharmacol. 2009, 241:322-328.
7. Biedermann S., Tschudin P., Grob K. Transfer of bisphenol A from thermal printer paper to the skin. Anal. Bioanal. Chem. 2010, 398:571-576.
8. Birnbaum L.S., Buche J.R., Collman G.W., Zeldin D.C., Johnson A.F., Schug T.T., Heindel J.J. Consortium-based science: the NIEHS's multipronged, collaborative approach to assessing the health effects of bisphenol A. Environ. Health Perspect. 2012, (Online).
9. Bloom M.S., Kim D., Vom Saal F.S., Taylor J.A., Cheng G., Lamb J.D., Fujimoto V.Y. Bisphenol A exposure reduces the estradiol response to gonadotropin stimulation during in vitro fertilization. Fertil. Steril. 2011, 96(672-677):e672.
10. Bloom M.S., Vom Saal F.S., Kim D., Taylor J.A., Lamb J.D., Fujimoto V.Y. Serum unconjugated bisphenol A concentrations in men may influence embryo quality indicators during in vitro fertilization. Environ. Toxicol. Pharmacol. 2011, 32:319-323.
11. Calafat A.M., Ye X., Wong L.Y., Reidy J.A., Needham L.L. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ. Health Perspect. 2008, 116:39-44.
12. Calafat A.M., Weuve J., Ye X., Jia L.T., Hu H., Ringer S., Huttner K., Hauser R. Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ. Health Perspect. 2009, 117:639-644.
13. Camacho, L., Kobets, T., Koturbash, I., Gordon Surratt, S.M.L., Vanlandingham, M.M., Churchwell, M., Doerge, D.R., Costa, G.G.d., Pogribny, I.P., Delclos, K.B., 2012. Global DNA Methylation and Gene Expression in the Prostate and Uterus of NCTR Sprague-Dawley Rats Orally Dosed with Bisphenol A, Society of Toxicology Annual Meeting, San Fracisco, CA.
14. Cao X.L., Corriveau J., Popovic S., Coughlan M.C., Chepelev N., Willmore W., Schrader T., Jin X. Background bisphenol A in experimental materials and its implication to low-dose in vitro study. Chemosphere 2010, 81:817-820.
15. Chapin R.E., Adams J., Boekelheide K., Gray L.E., Hayward S.W., Lees P.S., McIntyre B.S., Portier K.M., Schnorr T.M., Selevan S.G., Vandenbergh J.G., Woskie S.R. NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. Birth Defects Res. B Dev. Reprod. Toxicol. 2008, 83:157-395.
16. Churchwell, M., Camacho, L., vandlandingham, M., Twaddle, N.C., Sepehr, K., Delclos, K.B., Fisher, J.W., Doerge, D., 2013. Is Lifestage-dependent internal dosimetry for bisphenol A consistent with an estrogenic mode of action in Sprague Dawley rats when compared with a reference estrogen, ethinly estrodiol and exogenous estradiol? Toxicol. Sci. (submitted for publication).
17. Cobellis L., Colacurci N., Trabucco E., Carpentiero C., Grumetto L. Measurement of bisphenol A and bisphenol B levels in human blood sera from healthy and endometriotic women. Biomed. Chromatogr. 2009, 23:1186-1190.
18. Csanady G.A., Oberste-Frielinghaus H.R., Semder B., Baur C., Schneider K.T., Filser J.G. Distribution and unspecific protein binding of the xenoestrogens bisphenol A and daidzein. Arch. Toxicol. 2002, 76:299-305.
19. Dekant W., Volkel W. Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol. Appl. Pharmacol. 2008, 228:114-134.
20. Delclos K.B., Camacho L., Lewis S., Vanlandingham M., Chidambaram M., Churchwell M., Davis K., Doerge D., Costa G.G.d., Juliar B., Latendresse J., Olson S.M.G., Siitonen P., Thorn B., Trbojevich R., Woodling K. Effects of bisphenol A (BPA) and ethynl estradiol (EE, 2) in Sprague Dawley rats exposed orally from GD 6 through PND 90 the toxicologist CD. An Off. J. Soc. Toxicol. 2012, 371.
21. Dirtu A.C., Roosens L., Geens T., Gheorghe A., Neels H., Covaci A. Simultaneous determination of bisphenol A, triclosan, and tetrabromobisphenol A in human serum using solid-phase extraction and gas chromatography-electron capture negative-ionization mass spectrometry. Anal. Bioanal. Chem. 2008, 391:1175-1181.
22. Doerge D.R., Twaddle N.C., Vanlandingham M., Fisher J.W. Pharmacokinetics of bisphenol A in neonatal and adult Sprague-Dawley rats. Toxicol. Appl. Pharmacol. 2010, 247:158-165.
23. Doerge D.R., Twaddle N.C., Woodling K.A., Fisher J.W. Pharmacokinetics of bisphenol A in neonatal and adult rhesus monkeys. Toxicol. Appl. Pharmacol. 2010, 248:1-11.
24. Doerge D.R., Twaddle N.C., Vanlandingham M., Brown R.P., Fisher J.W. Distribution of bisphenol A into tissues of adult, neonatal, and fetal Sprague-Dawley rats. Toxicol. Appl. Pharmacol. 2011, 255:261-270.
25. Doerge D.R., Twaddle N.C., Vanlandingham M., Fisher J.W. Pharmacokinetics of bisphenol A in neonatal and adult CD-1 mice: inter-species comparisons with Sprague-Dawley rats and rhesus monkeys. Toxicol. Lett. 2011, 207:298-305.
26. Doerge D.R., Twaddle N.C., Vanlandingham M., Fisher J.W. Pharmacokinetics of bisphenol A in serum and adipose tissue following intravenous administration to adult female CD-1 mice. Toxicol. Lett. 2012, 211:114-119.
27. Duty S.M., Mendonca K., Hauser R., Calafat A.M., Ye X., Meeker J.D., Ackerman R., Cullinane J., Faller J., Ringer S. Potential sources of bisphenol a in the neonatal intensive care unit. Pediatrics 2013, 131:483-489.
28. European Food Safety Authority Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food on a request from the commission related to 2,2-BIS(4-HYDROXYPHENYL)PROPANE (Bisphenol A). EFSA J. 2007, 428:1-75.
29. Fisher J.W., Twaddle N.C., Vanlandingham M., Doerge D.R. Pharmacokinetic modeling: prediction and evaluation of route dependent dosimetry of bisphenol A in monkeys with extrapolation to humans 2011, Toxicol. Appl. Pharmacol.
30. Food and Drug Administration, 2009. Exposure to Bisphenol A (BPA) for infants, toblers and adults from the consumption of infant formula, toddler food and adult (canned) food. In: C.T. Division of Biotechnology and GRAS Notice Reivew. Food and Drug Administration, Wahington, DC.
31. Fujimaki K., Arakawa C., Yoshinaga J., Watanabe C., Serizawa S., Imai H., Shiraishi H., Mizumoto Y. Estimation of Intake Level of bisphenol A in Japanese pregnant woment based on measurement of urinary excretion level of the metabolite. Nippon Eiseigaku Zashi 2004, 59.
32. Geens T., Apelbaum T.Z., Goeyens L., Neels H., Covaci A. Intake of bisphenol A from canned beverages and foods on the Belgian market. Food Addit. Contam. Part A Chem. Anal. Control Expo Risk Assess 2010, 27:1627-1637.
33. Geens T., Aerts D., Berthot C., Bourguignon J.P., Goeyens L., Lecomte P., Maghuin-Rogister G., Pironnet A.M., Pussemier L., Scippo M.L., Van Loco J., Covaci A. A review of dietary and non-dietary exposure to bisphenol-A. Food Chem. Toxicol. 2012, 50:3725-3740.
34. Giguere V. To ERR in the estrogen pathway. Trends Endocrinol. Metab. 2002, 13:220-225.
35. Goodson W.H., Luciani M.G., Sayeed S.A., Jaffee I.M., Moore D.H., Dairkee S.H. Activation of the mTOR pathway by low levels of xenoestrogens in breast epithelial cells from high-risk women. Carcinogenesis 2011, 32:1724-1733.
36. Gray W.G., Biswas E.E., Bashirelahi N., Biswas S.B. A low-affinity estrogen-binding site in pregnant rat uteri: analysis and partial purification. Proc. Natl. Acad. Sci. USA 1994, 91:11502-11506.
37. Gyllenhammar I., Glynn A., Darnerud P.O., Lignell S., van Delft R., Aune M. 4-Nonylphenol and bisphenol A in Swedish food and exposure in Swedish nursing women. Environ. Int. 2012, 43C:21-28.
38. Hiroi H., Tsutsumi O., Takeuchi T., Momoeda M., Ikezuki Y., Okamura A., Yokota H., Taketani Y. Differences in serum bisphenol a concentrations in premenopausal normal women and women with endometrial hyperplasia. Endocr. J. 2004, 51:595-600.
39. Hugo E.R., Brandebourg T.D., Woo J.G., Loftus J., Alexander J.W., Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ. Health Perspect. 2008, 116:1642-1647.
40. Hunt P.A., Lawson C., Gieske M., Murdoch B., Smith H., Marre A., Hassold T., VandeVoort C.A. Bisphenol A alters early oogenesis and follicle formation in the fetal ovary of the rhesus monkey. Proc. Natl. Acad. Sci. USA 2012, 109:17525-17530.
41. Ikezuki Y., Tsutsumi O., Takai Y., Kamei Y., Taketani Y. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum. Reprod. 2002, 17:2839-2841.
42. Inoue H., Yuki G., Yokota H., Kato S. Bisphenol A glucuronidation and absorption in rat intestine. Drug Metab. Dispos. 2003, 31:140-144.
43. Jasarevic E., Williams S.A., Vandas G.M., Ellersieck M.R., Liao C., Kannan K., Roberts R.M., Geary D.C., Rosenfeld C.S. Sex and dose-dependent effects of developmental exposure to bisphenol A on anxiety and spatial learning in deer mice (Peromyscus maniculatus bairdii) offspring. Horm. Behav. 2013, 63:180-189.
44. Jeyakumar M., Carlson K.E., Gunther J.R., Katzenellenbogen J.A. Exploration of dimensions of estrogen potency: parsing ligand binding and coactivator binding affinities. J. Biol. Chem. 2011, 286:12971-12982.
45. Kaddar N., Bendridi N., Harthe C., de Ravel M.R., Bienvenu A.L., Cuilleron C.Y., Mappus E., Pugeat M., Dechaud H. Development of a radioimmunoassay for the measurement of Bisphenol A in biological samples. Anal. Chim. Acta 2009, 645:1-4.
46. Kandaraki E., Chatzigeorgiou A., Livadas S., Palioura E., Economou F., Koutsilieris M., Palimeri S., Panidis D., Diamanti-Kandarakis E. Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. J. Clin. Endocrinol. Metab. 2011, 96:E480-484.
47. Koch H.M., Calafat A.M. Human body burdens of chemicals used in plastic manufacture. Philos. Trans. Roy. Soc. Lond. B Biol. Sci. 2009, 364:2063-2078.
48. Koch H.M., Kolossa-Gehring M., Schroter-Kermani C., Angerer J., Bruning T. Bisphenol A in 24 h urine and plasma samples of the German Environmental Specimen Bank from 1995 to 2009: a retrospective exposure evaluation 2012, J. Expo Sci. Environ. Epidemiol.
49. Kuiper G.G.J.M., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.-Å. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 1997, 138:863-870.
50. Kurebayashi H., Harada R., Stewart R.K., Numata H., Ohno Y. Disposition of a low dose of bisphenol a in male and female cynomolgus monkeys. Toxicol. Sci. 2002, 68:32-42.
51. Kuroda N., Kinoshita Y., Sun Y., Wada M., Kishikawa N., Nakashima K., Makino T., Nakazawa H. Measurement of bisphenol A levels in human blood serum and ascitic fluid by HPLC using a fluorescent labeling reagent. J. Pharm. Biomed. Anal. 2003, 30:1743-1749.
52. Lakind J.S., Naiman D.Q. Bisphenol A (BPA) daily intakes in the United States: estimates from the 2003-2004 NHANES urinary BPA data. J. Expo Sci. Environ. Epidemiol. 2008, 18:608-615.
53. Lakind J.S., Naiman D.Q. Daily intake of bisphenol A and potential sources of exposure: 2005-2006 National Health and Nutrition Examination Survey. J. Expo Sci. Environ. Epidemiol. 2010, 2:1-8.
54. Lakind J.S., Naiman D.Q. Daily intake of bisphenol A and potential sources of exposure: 2005-2006 National Health and Nutrition Examination Survey. J. Expo Sci. Environ. Epidemiol. 2011, 21:272-279.
55. Lakind J.S., Goodman M., Naiman D.Q. Use of NHANES data to link chemical exposures to chronic diseases: a cautionary tale. PLoS One 2012, 7:e51086. (doi:51010.51371/journal.pone.0051086. Epub 0052012 December 0051085).
56. Lakind J.S., Levesque J., Dumas P., Bryan S., Clarke J., Naiman D.Q. Comparing United States and Canadian population exposures from National Biomonitoring Surveys: bisphenol A intake as a case study. J. Expo Sci. Environ. Epidemiol. 2012, 22:219-226.
57. Lang I.A., Galloway T.S., Scarlett A., Henley W.E., Depledge M., Wallace R.B., Melzer D. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008, 300:1303-1310.
58. Liao C., Kannan K. Determination of free and conjugated forms of bisphenol A in human urine and serum by liquid chromatography-tandem mass spectrometry. Environ. Sci. Technol. 2012, 46:5003-5009.
59. Liu M., Hashi Y., Pan F., Yao J., Song G., Lin J.M. Automated on-line liquid chromatography-photodiode array-mass spectrometry method with dilution line for the determination of bisphenol A and 4-octylphenol in serum. J. Chromatogr. A 2006, 1133:142-148.
60. Liu X., Matsushima A., Okada H., Tokunaga T., Isozaki K., Shimohigashi Y. Receptor binding characteristics of the endocrine disruptor bisphenol A for the human nuclear estrogen-related receptor gamma. Chief and corroborative hydrogen bonds of the bisphenol A phenol-hydroxyl group with Arg316 and Glu275 residues. FEBS J. 2007, 274:6340-6351.
61. Loganathan S.N., Kannan K. Occurrence of bisphenol A in indoor dust from two locations in the eastern United States and implications for human exposures. Arch. Environ. Contam. Toxicol. 2011, 61:68-73.
62. Maffini M.V., Rubin B.S., Sonnenschein C., Soto A.M. Endocrine disruptors and reproductive health: the case of bisphenol-A. Mol. Cell. Endocrinol. 2006, 254-255:179-186.
63. Markham D.A., Waechter J.M., Wimber M., Rao N., Connolly P., Chuang J.C., Hentges S., Shiotsuka R.N., Dimond S., Chappelle A.H. Development of a method for the determination of bisphenol a at trace concentrations in human blood and urine and elucidation of factors influencing method accuracy and sensitivity. J. Anal. Toxicol. 2010, 34:293-303.
64. Mendel C.M. The free hormone hypothesis: distinction from the free hormone transport hypothesis. J. Androl. 1992, 13:107-116.
65. Moors S., Blaszkewicz M., Bolt H.M., Degen G.H. Simultaneous determination of daidzein, equol, genistein and bisphenol A in human urine by a fast and simple method using SPE and GC-MS. Mol. Nutr. Food Res. 2007, 51:787-798.
66. Morgan M.K., Jones P.A., Calafat A.M., Ye X., Croghan C.W., Chuang J.C., Wilson N.K., Clifton M.S., Figueroa Z., Sheldon L.S. Assessing the quantitative relationships between preschool children's exposures to bisphenol A by route and urinary biomonitoring. Environ. Sci. Technol. 2011, 45:5309-5316.
67. Nadal A., Alonso-Magdalena P., Soriano S., Quesada I., Ropero A.B. The pancreatic beta-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes. Mol. Cell. Endocrinol. 2009, 304:63-68.
68. Nikov G.N., Hopkins N.E., Boue S., Alworth W.L. Interactions of dietary estrogens with human estrogen receptors and the effect on estrogen receptor-estrogen response element complex formation. Environ. Health Perspect. 2000, 108:867-872.
69. Okada H., Tokunaga T., Liu X., Takayanagi S., Matsushima A., Shimohigashi Y. Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma. Environ. Health Perspect. 2008, 116:32-38.
70. Ouchi K., Watanabe S. Measurement of bisphenol A in human urine using liquid chromatography with multi-channel coulometric electrochemical detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002, 780:365-370.
71. Padmanabhan V., Siefert K., Ransom S., Johnson T., Pinkerton J., Anderson L., Tao L., Kannan K. Maternal bisphenol-A levels at delivery: a looming problem?. J. Perinatol. 2008, 28:258-263.
72. Pardridge W. Transport of protein-bound hormones into tissues in vivo. Endocr. Rev. 1981, 2:103-123.
73. Patterson T.A., Twaddle N.C., Roegge C.S., Callicott R.J., Fisher J.W., Doerge D.R. Concurrent determination of bisphenol A pharmacokinetics in maternal and fetal rhesus monkeys. Toxicol. Appl. Pharmacol. 2013, 267:41-48.
74. Plowchalk, D.R., Teeguarden, J.G., 2002. Physiologically based models for estradiol pharmacokinetics in rats and humans. Final Report. Toxicol. Sci. (in press).
75. Regitz-Zagrosek V., Wintermantel T.M., Schubert C. Estrogens and SERMs in coronary heart disease. Curr. Opin. Pharmacol. 2007, 7:130-139.
76. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307:1625-1630.
77. Revankar C.M., Mitchell H.D., Field A.S., Burai R., Corona C., Ramesh C., Sklar L.A., Arterburn J.B., Prossnitz E.R. Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30. ACS Chem. Biol. 2007, 2:536-544.
78. Rosenfeld C.S., Sieli P.T., Warzak D.A., Ellersieck M.R., Pennington K.A., Roberts R.M. Maternal exposure to bisphenol A and genistein has minimal effect on Avy/a offspring coat color but favors birth of agouti over nonagouti mice. Proc. Natl. Acad. Sci. USA 2013, 110:537-542.
79. Sajiki J., Takahashi K., Yonekubo J. Sensitive method for the determination of bisphenol-A in serum using two systems of high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 1999, 736:255-261.
80. Schonfelder G., Wittfoht W., Hopp H., Talsness C.E., Paul M., Chahoud I. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ. Health Perspect. 2002, 110:A703-707.
81. Schug T.T., Janesick A., Blumberg B., Heindel J.J. Endocrine disrupting chemicals and disease susceptibility. J. Steroid Biochem. Mol. Biol. 2011, 127:204-215. (doi:210.1016/j.jsbmb.2011.1008.1007. Epub 2011 August 1027).
82. Sugiura-Ogasawara M., Ozaki Y., Sonta S., Makino T., Suzumori K. Exposure to bisphenol A is associated with recurrent miscarriage. Hum. Reprod. 2005, 20:2325-2329.
83. Takeuchi T., Tsutsumi O. Serum bisphenol a concentrations showed gender differences, possibly linked to androgen levels. Biochem. Biophys. Res. Commun. 2002, 291:76-78.
84. Takeuchi T., Tsutsumi O., Ikezuki Y., Takai Y., Taketani Y. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr. J. 2004, 51:165-169.
85. Tan B.L., Ali Mohd M. Analysis of selected pesticides and alkylphenols in human cord blood by gas chromatograph-mass spectrometer. Talanta 2003, 61:385-391.
86. Taylor J.A., Vom Saal F.S., Welshons W.V., Drury B., Rottinghaus G., Hunt P.A., Vandevoort C.A. Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ. Health Perspect. 2011, 119:422-430.
87. Teeguarden J.G., Waechter J.M., Clewell H.J., Covington T.R., Barton H.A. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach. Toxicol. Sci. 2005, 85:823-838.
88. Teeguarden J.G., Calafat A.M., Ye X., Doerge D.R., Churchwell M.I., Gunawan R., Graham M.K. Twenty-four hour human urine and serum profiles of bisphenol A during high-dietary exposure. Toxicol. Sci. 2011, 123:48-57.
89. Teeguarden, J.G., Hanson-Drury, S.A., 2013. systematic review of Bisphenol A "Low Dose" studies in the context of human exposure: A case for establishing standards for reporting "low-dose" effects of chemicals. Food Chem Toxicol.
90. Tharp A.P., Maffini M.V., Hunt P.A., VandeVoort C.A., Sonnenschein C., Soto A.M. Bisphenol A alters the development of the rhesus monkey mammary gland. Proc. Natl. Acad. Sci. USA 2012, 109:8190-8195.
91. Thomas P., Dong J. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J. Steroid Biochem. Mol. Biol. 2006, 102:175-179.
92. Tsakovska I., Pajeva I., Alov P., Worth A. Recent advances in the molecular modeling of estrogen receptor-mediated toxicity. Adv. Protein Chem. Struct. Biol. 2011, 85:217-251.
93. Tsukioka T., Terasawa J., Sato S., Hatayama Y., Makino K., Nakazawa H. Development of a analytical method of determining trace amount of BPA in ruine samples and estimation of exposure to BPA. J. Environ. Chem. 2004, 14:57-63.
94. Twaddle N.C., Churchwell M.I., Vanlandingham M., Doerge D.R. Quantification of deuterated bisphenol A in serum, tissues, and excreta from adult Sprague-Dawley rats using liquid chromatography with tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2010, 24:3011-3020.
95. Tyl R.W., Myers C.B., Marr M.C., Thomas B.F., Keimowitz A.R., Brine D.R., Veselica M.M., Fail P.A., Chang T.Y., Seely J.C., Joiner R.L., Butala J.H., Dimond S.S., Cagen S.Z., Shiotsuka R.N., Stropp G.D., Waechter J.M. Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxicol. Sci. 2002, 68:121-146.
96. Tyl R.W., Myers C.B., Marr M.C., Sloan C.S., Castillo N.P., Veselica M.M., Seely J.C., Dimond S.S., Van Miller J.P., Shiotsuka R.N., Beyer D., Hentges S.G., Waechter J.M. Two-generation reproductive toxicity study of dietary bisphenol A in CD-1 (Swiss) mice. Toxicol. Sci. 2008, 104:362-384.
97. Vandenberg L.N., Maffini M.V., Sonnenschein C., Rubin B.S., Soto A.M. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr. Rev. 2009, 30:75-95.
98. Vandenberg L.N., Chahoud I., Heindel J.J., Padmanabhan V., Paumgartten F.J., Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ. Health Perspect. 2010, 118:1055-1070.
99. Vandenberg L.N., Colborn T., Hayes T.B., Heindel J.J., Jacobs D.R.Jr., Lee D.H., Shioda T., Soto A.M., vom Saal F.S., Welshons W.V., Zoeller R.T., Myers J.P. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr. Rev. 2012, 33:378-455.
100. Vandenberg L.N., Hunt P.A., Myers J.P., Frederick S.v.S. Human expsoures to bisphenol A: mismatches between data and assumptions. Rev. Environ. Health 2013, 28:37-58.
101. Vandentorren S., Zeman F., Morin L., Sarter H., Bidondo M.-L., Oleko A., Leridon H. Bisphenol-A and phthalates contamination of urine samples by catheters in the Elfe pilot study: implications for large-scale biomonitoring studies. Environ. Res. 2011, 111:761-764.
102. Veiga-Lopez A., Luense L.J., Christenson L.K., Padmanabhan V. Developmental programming: gestational bisphenol-a treatment alters trajectory of fetal ovarian gene expression. Endocrinology 2013, 154:1873-1884.
103. Völkel W., Colnot T., Csanady G.A., Filser J.G., Dekant W. Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem. Res. Toxicol. 2002, 15:1281-1287.
104. Völkel W., Bittner N., Dekant W. Quantitation of bisphenol A and bisphenol A glucuronide in biological samples by high performance liquid chromatography-tandem mass spectrometry. Drug Metab. Dispos. 2005, 33:1748-1757.
105. Völkel W., Kiranoglu M., Fromme H. Determination of free and total bisphenol A in urine of infants. Environ. Res. 2011, 111:143-148.
106. Wan Y., Choi K., Kim S., Ji K., Chang H., Wiseman S., Jones P.D., Khim J.S., Park S., Park J., Lam M.H., Giesy J.P. Hydroxylated polybrominated diphenyl ethers and bisphenol A in pregnant women and their matching fetuses: placental transfer and potential risks. Environ. Sci. Technol. 2010, 44:5233-5239.
107. Washington W., Hubert L., Jones D., Gray W.G. Bisphenol a binds to the low-affinity estrogen binding site. In Vitro Mol. Toxicol. 2001, 14:43-51.
108. Welshons W.V., Thayer K.A., Judy B.M., Taylor J.A., Curran E.M., vom Saal F.S. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ. Health Perspect. 2003, 111:994-1006.
109. Wolff M.S., Teitelbaum S.L., Windham G., Pinney S.M., Britton J.A., Chelimo C., Godbold J., Biro F., Kushi L.H., Pfeiffer C.M., Calafat A.M. Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls. Environ. Health Perspect. 2007, 115:116-121.
110. World Health Organization, 2011. Toxicological and Health Aspects of Bisphenol A: Report of Joint FAO/WHO Expert Meeting 2-5 November 2010 and Report of Stakeholder Meeting on Bisphenol A. World Health Organization, Ottawa, CA, p. 60.
111. World Health Organization, Food and Agriculture Organization of the United Nations, 2011. Toxicological and Health Aspects of Bisphenol A: Report of Joint FAO/WHO Expert Meeting 2-5 November 2010 and Report of Stakeholder Meeting on Bisphenol A 1 November 2010. World Health Organization Press, Geneva.
112. Yang X., Doerge D.R., Fisher J.W. Prediction and evaluation of route dependent dosimetry of BPA in rats at different life stages using a physiologically based pharmacokinetic model. Toxicol. Appl. Pharmacol. 2013.
113. Ye X., Wong L.Y., Bishop A.M., Calafat A.M. Variability of urinary concentrations of bisphenol A in spot samples, first-morning voids, and 24-hour collections. Environ. Health Perspect. 2011, 119:983-988.
114. Ye X., Zhou X., Hennings R., Kramer J., Calafat A.M. Potential external contamination with bisphenol A and other ubiquitous organic environmental chemicals during biomonitoring analysis: an elusive laboratory challenge. Environ. Health Perspect. 2013, 121:283-286.
115. Yonekubo J., Hayakawa K., Sajiki J. Concentrations of bisphenol a, bisphenol a diglycidyl ether, and their derivatives in canned foods in Japanese markets. J. Agric. Food Chem. 2008, 56:2041-2047.
116. Yoshimura Y., Brock J.W., Makino T., Nakazawa H. Measurement of bisphenol A in human serum by gas chromatography/mass spectrometry. Anal. Chem. Acta 2002, 458:331-336.
117. Zhang T., Sun H., Kannan K. Blood and urinary bisphenol A concentrations in children, adults, and pregnant women from china: partitioning between blood and urine and maternal and fetal cord blood. Environ. Sci. Technol. 2013.